Teva achieves “major landmark” with office move

Teva has achieved a “major landmark” in its development as it has moved all of its products to a new site.

In a statement, the firm explained that, as part of plans to make the transition as smooth as possible, it carried out a staggered move of its products, shifting a couple of lines at a time in order to minimise disruption to its business.

Commenting, Richard Daniell, Teva’s senior director, said: “I’m delighted that we have achieved this major landmark. The move helps consolidate our position as one of the UK’s leading pharmaceutical companies.”

The transition will benefit customers as Teva now has the space and facilities to provide the best service possible, he added.

Mr Daniell extended a “personal thank you” to all the company’s clients for being patient over the course of the transition.

Earlier this month, the firm donated a total of 12.1 million pounds’ worth of products to International Health Partners.